Home Idorsia

Idorsia

In operation
Post-IPO Round
Pharmaceutical R&D Developer
Basic
Enterprise Profile

Basic Information

Idorsia specializes in the discovery, development, and commercialization of small molecules to transform the range of therapeutic options. With a 20-year history in drug discovery, Idorsia boasts a broad portfolio of innovative medicines and an experienced professional team covering all disciplines from clinical to bedside. Operating commercially in Europe, Japan, and the United States, Idorsia is ideally positioned to bring innovative medicines to patients.
Idorsia Pharmaceuticals, Ltd.
CantonBasel-Landschaft,Switzerland
more than 500 people
June 01, 2017
info@idorsia.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Drug Active Pharmaceutical Ingredients
Technology
Cell Technology
Concept
Department of Pharmacy
Application Scenarios
Biologics Chemical Drug Innovative Drugs